• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Up­dat­ed: Ver­tex un­veils PhI­II plans for non-opi­oid drug fol­low­ing mid-stage suc­cess in pe­riph­er­al neu­ro­path­ic pain

Last year
R&D

Ex­clu­sive: Park­er In­sti­tute ex­pands to Weill Cor­nell Med­i­cine as it grows im­munother­a­py work

Last year
R&D

Im­munother­a­py biotech rais­es $37M from back­ers like Pfiz­er, Take­da, BMS

Last year
Financing

UMass med­ical school’s man­u­fac­tur­ing busi­ness trims 36 po­si­tions

Last year
People
Manufacturing

House pass­es sweep­ing health­care price trans­paren­cy re­forms, rein­ing in PBM prac­tices

Last year
Pharma
FDA+

No­vo Nordisk calls IRA 'un­prece­dent­ed de­par­ture' from US Con­sti­tu­tion

Last year
Pharma
Law

Cor­rect­ed: Dizal presents up­dat­ed PhII PT­CL da­ta, plans to file for ac­cel­er­at­ed ap­proval in the US next year

Last year
R&D

FDA es­tab­lish­es new ad­vi­so­ry com­mit­tee for ge­net­ic meta­bol­ic dis­ease treat­ments

Last year
Pharma
FDA+

Over 200 crit­i­cal med­i­cines to be mon­i­tored for short­ages in the EU 

Last year
Manufacturing

FDA rolls out new draft guid­ance on ad­vanced man­u­fac­tur­ing tech

Last year
Pharma
FDA+

Bis­pecifics con­tin­ue im­pres­sive ef­fi­ca­cy streak, but com­pa­nies look to re­duce side ef­fects: #ASH23

Last year
R&D

Mar­ket­ingRx roundup: Ab­b­Vie, Sanofi and Re­gen­eron lead phar­ma ad spend; BMS launch­es new eq­ui­ty grants

Last year
Pharma
Marketing

J&J and Gen­mab tout first-line in­jectable Darza­lex for mul­ti­ple myelo­ma: #ASH23

Last year
R&D

Re­silience plans to ex­pand Ohio fa­cil­i­ty with 440 new jobs over three years

Last year
Manufacturing

Almi­rall part­ners with eth­er­na; Dai­ichi's RNA deal with De­pixus; SQZ founder's start­up emerges from stealth

Last year
News Briefing

Mod­er­na's chief com­mer­cial of­fi­cer out as com­pa­ny re­or­ga­nizes

Last year
People
Marketing

Icosavax buy­out caps As­traZeneca’s long search for a vac­cine plat­form

Last year
Deals
Pharma

Af­ter ground­break­ing year for RSV ap­provals, GSK looks to mod­el pe­di­atric suc­cess for adult vac­cines

Last year
Pharma
Marketing

Klick Health of­fers $1M prize pool for agency em­ploy­ees with in­no­v­a­tive AI so­lu­tions

Last year
Pharma
Marketing

Mer­ck ex­tends ADC push by lend­ing a hand to C4 with small up­front for pro­tein de­grad­er work

Last year
Deals
Pharma

FDA sets late 2024 de­ci­sion dead­line for Pfiz­er’s 'pan-he­mo­phil­i­a' drug: #ASH23

Last year
R&D
FDA+

Why the pres­i­dent of Kroger Health is bet­ting the gro­cery gi­ant can use food as med­i­cine

Last year
Health Tech

MIT gene edit­ing spin­out launch­es with $213M to write the 'fi­nal chap­ter in ge­nom­ic med­i­cine'

Last year
Financing
Startups

Ex­clu­sive: Shi­no­bi rais­es $51M to take on cell ther­a­py chal­lenges with ex-Wu­gen CEO at helm, Carl June in sup­port

Last year
Financing
Startups
First page Previous page 231232233234235236237 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times